Loading
Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials.
Martin Bornhäuser is one of three Managing Directors of the National Center for Tumor Diseases (NCT/UCC) Dresden and Director of Medizinische Klinik und Poliklinik I at University Hospital Carl Gustav Carus. His research focuses on allogeneic stem cell transplantation and acute myeloid leukaemia, including the ASAP trial of immediate transplantation in relapsed or refractory AML. His role is listed on the NCT/UCC Direktorium page.
| Title | Journal | Year |
|---|---|---|
| Multiple myeloma | Lancet | 2015 |
| Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP) | Lancet Haematology | 2024 |
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia, Multiple myeloma and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia, Multiple myeloma and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.